News in the Life Sciences Industry

- Global clinical development program of quizartinib continues with focus on newly-diagnosed FLT3-ITD AML with enrollment completed into pivotal phase 3 QuANTUM-First study

LAS VEGAS, Oct. 17, 2019 /PRNewswire/ -- In the halls of the SupplySide West (SSW) Expo, officials from both GELITA and Geltor signed a letter of intent for developing, producing and marketing the first ingestible animal-free collagen proteins - to be launched in late 2020. In this arrangement,... Read more ››

ABBOTT PARK, Ill., Oct. 16, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2019.

LONDON, Oct. 16, 2019 /CNW/ - Fineqia International Inc. (the "Company" or "Fineqia") (CSE: FNQ) (OTC: FNQQF) (Frankfurt: FNQA) is pleased to announce its U.K. subsidiary Fineqia Limited ("Fineqia Ltd") has successfully arranged for the issuance and subscription of a €2.94 million bond against... Read more ››

The companies will continue to collaborate in the Australian market

HUNTSVILLE, Ala., Oct. 15, 2019 /PRNewswire/ -- Discovery Life Sciences(TM)(Discovery) announced today its substantial investment in long-read genomic sequencing technology from Pacific Biosciences (PacBio). The instrumentation will complement the existing infrastructure of HudsonAlpha Discovery(TM),... Read more ››

REHOVOT, Israel, Oct. 14, 2019 /PRNewswire/ -- Pi-Cardia Ltd. (www.pi-cardia.net), announced today the appointment of Prof. Jacques Séguin, former CoreValve Founder and CEO and serial medical device entrepreneur, as Chairman of its Board... Read more ››

Nearly 40,000 people still die from this preventable disorder in Europe every year

MADRID, Oct. 11, 2019 /PRNewswire/ -- Poor dietary habits, increased stress and harsh skincare routines are among the most significant factors associated with acne, a new study has found.

MUMBAI, Oct. 11, 2019 /PRNewswire/ -- Johnson & Johnson today announced it has committed to ensuring more than $500 million is dedicated to world class research & development and delivery programs over the next four years to accelerate global efforts to eliminate HIV and tuberculosis... Read more ››

OSAKA, Japan, Oct. 11, 2019 /PRNewswire/ -- Shionogi & Co., Ltd. (Head Office: Osaka; President and CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") today announced that it has entered into a new license agreement with Hsiri Therapeutics, Inc. (Head Office: Media, PA, USA; President and... Read more ››

MADRID, Oct. 9, 2019 /PRNewswire/ -- At the European Academy of Dermatology and Venereology (EADV) annual meeting 10-12 October, in Madrid, Spain, Canfield Scientific will showcase several new, innovative AI-driven dermatology solutions along with significant enhancements to their aesthetic solutions.